Home Access Health Targets Federal "Lookback" Program For Home HCV Test
This article was originally published in The Gray Sheet
Home Access Health's strategy to target hospitals and transfusion centers in offering a home hepatitis C (HCV) testing and counseling service is designed to reach a group of individuals who likely are in need of testing because of exposure to HCV-tainted products.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.